Agoracom: Small Cap Investment - Zenith Epigenetics - Re: Priceless on I.V. Regarding Zenith

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Priceless on I.V. Regarding Zenith

SanFrancisco99

Apr 07, 2017 11:24AM

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Priceless on I.V. Regarding Zenith

in response to

Priceless on I.V. Regarding Zenith

SanFrancisco99

posted on Apr 07, 2017 12:32PM

On Monday I emailed Zenith asking about Q2 events, posting the AACR poster, and when there will be a clinical trial and corporate update. She responded on Wednesday "As soon as I have all the answers for you re Zenith I will get back to you." I haven't heard anything yet. It is unusual for it to take this long for a response.

BearDownAZ

1 Recommendations

Re: Priceless on I.V. Regarding Zenith

SanFrancisco99

Apr 07, 2017 04:19PM

Re: Priceless on I.V. Regarding Zenith

BearDownAZ

Apr 08, 2017 12:29PM

Re: Priceless on I.V. Regarding Zenith

SanFrancisco99

Apr 08, 2017 06:38PM

Re: Priceless on I.V. Regarding Zenith